BACKGROUND: Increased serotonin (5-hydroxytryptamine [5HT]) receptor (5HTR) signaling has been associated with cardiac valvulopathy. Prior cell culture studies of 5HTR signaling in heart valve interstitial cells have provided mechanistic insights concerning only static conditions. We investigated the hypothesis that aortic valve biomechanics participate in the regulation of both 5HTR expression and interrelated extracellular matrix remodeling events. METHODS: The effects of cyclic stretch on aortic valve 5HTR, expression, signaling, and extracellular matrix remodeling were investigated using a tensile stretch bioreactor in studies which also compared the effects of adding 5HT and (or) the 5HT-transporter inhibitor, fluoxetine. RESULTS: Cyclic stretch alone increased both proliferation and collagen in porcine aortic valve cusp samples. However, with cyclic stretch, unlike static conditions, 5HT plus fluoxetine caused the greatest increase in proliferation (p<0.0001), and also caused significant increases in collagen (p<0.0001) and glycosaminoglycans (p<0.0001). The DNA microarray data demonstrated upregulation of 5HTR2A and 5HTR2B (>4.5-fold) for cyclic stretch versus static (p<0.001), while expression of the 5HT transporter was not changed significantly. Extracellular matrix genes (eg, collagen types I, II, III, and proteoglycans) were also upregulated by cyclic stretch. CONCLUSIONS: Porcine aortic valve cusp samples subjected to cyclic stretch upregulate 5HTR2A and 2B, and also initiate remodeling activity characterized by increased proliferation and collagen production. Importantly, enhanced 5HTR responsiveness due to increased 5HTR2A and 2B expression results in a significantly greater response in remodeling endpoints (proliferation, collagen, and GAG production) to 5HT in the presence of 5HT transporter blockade.
BACKGROUND: Increased serotonin (5-hydroxytryptamine [5HT]) receptor (5HTR) signaling has been associated with cardiac valvulopathy. Prior cell culture studies of 5HTR signaling in heart valve interstitial cells have provided mechanistic insights concerning only static conditions. We investigated the hypothesis that aortic valve biomechanics participate in the regulation of both 5HTR expression and interrelated extracellular matrix remodeling events. METHODS: The effects of cyclic stretch on aortic valve 5HTR, expression, signaling, and extracellular matrix remodeling were investigated using a tensile stretch bioreactor in studies which also compared the effects of adding 5HT and (or) the 5HT-transporter inhibitor, fluoxetine. RESULTS: Cyclic stretch alone increased both proliferation and collagen in porcine aortic valve cusp samples. However, with cyclic stretch, unlike static conditions, 5HT plus fluoxetine caused the greatest increase in proliferation (p<0.0001), and also caused significant increases in collagen (p<0.0001) and glycosaminoglycans (p<0.0001). The DNA microarray data demonstrated upregulation of 5HTR2A and 5HTR2B (>4.5-fold) for cyclic stretch versus static (p<0.001), while expression of the 5HT transporter was not changed significantly. Extracellular matrix genes (eg, collagen types I, II, III, and proteoglycans) were also upregulated by cyclic stretch. CONCLUSIONS: Porcine aortic valve cusp samples subjected to cyclic stretch upregulate 5HTR2A and 2B, and also initiate remodeling activity characterized by increased proliferation and collagen production. Importantly, enhanced 5HTR responsiveness due to increased 5HTR2A and 2B expression results in a significantly greater response in remodeling endpoints (proliferation, collagen, and GAG production) to 5HT in the presence of 5HT transporter blockade.
Authors: Nurith Kurn; Pengchin Chen; Joe Don Heath; Anne Kopf-Sill; Kathryn M Stephens; Shenglong Wang Journal: Clin Chem Date: 2005-08-25 Impact factor: 8.327
Authors: A Mekontso-Dessap; F Brouri; O Pascal; P Lechat; N Hanoun; L Lanfumey; I Seif; N Benhaiem-Sigaux; M Kirsch; M Hamon; S Adnot; S Eddahibi Journal: Circulation Date: 2005-12-27 Impact factor: 29.690
Authors: Steven Droogmans; Philippe R Franken; Christian Garbar; Caroline Weytjens; Bernard Cosyns; Tony Lahoutte; Vicky Caveliers; Miriam Pipeleers-Marichal; Axel Bossuyt; Danny Schoors; Guy Van Camp Journal: Eur Heart J Date: 2007-07-18 Impact factor: 29.983
Authors: Kartik Balachandran; Patrick W Alford; Jill Wylie-Sears; Josue A Goss; Anna Grosberg; Joyce Bischoff; Elena Aikawa; Robert A Levine; Kevin Kit Parker Journal: Proc Natl Acad Sci U S A Date: 2011-11-28 Impact factor: 11.205
Authors: Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari Journal: Cardiovasc Pathol Date: 2020-01-07 Impact factor: 2.185
Authors: Jacqueline H Fortier; Beatrice Pizzarotti; Richard E Shaw; Robert J Levy; Giovanni Ferrari; Juan Grau Journal: Heart Date: 2019-05-25 Impact factor: 5.994
Authors: Sammy Elmariah; Joseph A C Delaney; David A Bluemke; Matthew J Budoff; Kevin D O'Brien; Valentin Fuster; Richard A Kronmal; Jonathan L Halperin Journal: JACC Cardiovasc Imaging Date: 2012-08
Authors: Elliott Goldberg; Juan B Grau; Jacqueline H Fortier; Elisa Salvati; Robert J Levy; Giovanni Ferrari Journal: Cardiovasc Res Date: 2017-07-01 Impact factor: 10.787
Authors: Emily J Farrar; Varsha Pramil; Jennifer M Richards; Christopher Z Mosher; Jonathan T Butcher Journal: Biomaterials Date: 2016-07-29 Impact factor: 12.479